Navigation Links
Does Your Business Have the Tools to Compete in the World's Largest Diagnostics Markets?
Date:10/30/2013

MOUNTAIN VIEW, Calif., Oct. 30, 2013 /PRNewswire/ -- The inclusive and increasingly competitive in vitro diagnostics (IVD) landscape is evolving in unison with healthcare reform. Therefore, it is vital for all market participants to understand the transformation and manage amidst the changes.  Those even remotely invested in the market require crucial insight on business strategy and regulatory and technological advancements essential for success, in addition to current and future growth trends and market opportunities that will keep them a key player.

"Global IVD companies have been forced to adjust to a lower healthcare spending baseline for what is currently the world's largest IVD market, the United States," said Frost & Sullivan Life Sciences Senior Industry Analyst Winny Tan. "We used to describe the diagnostics market as highly cost-sensitive; now it is the entire healthcare industry that is cost-constrained. Competing in this business environment means growth strategies need to deliver the greatest value with low upfront investments. Potential strategies that fit a cost-constrained industry include identifying underpenetrated markets, leveraging external innovation partners and taking advantage of existing data."

To evaluate these strategies, Tan participates in IVD Business Strategy Conference (http://www.ivdtconference.com/), taking place Nov. 6-8, 2013, in San Diego, Calif.  Her presentation, "Evaluating Diagnostic Industry Growth Trends and Market Opportunities in Global Markets," is on day one of the event and will provide a competitive overview through an analysis of the global IVD market; an evaluation of market revenue opportunities, segment sizes and growth rates; and an assessment of emerging IVD markets.

IVD Business Strategy Conference 2013 provides a full scope view of the business strategy, regulatory and technology advancements essential to generating success in the IVD marketplace.  The event will feature real world case studies by providers as well as a half-day supplemental workshop on reimbursement strategies facilitated by Emerson Consulting.

This all-inclusive two-day conference program covers a range of topics to develop and successfully commercialize in vitro diagnostics, including what's to come for the IVD business landscape and identifying domestic and global growth trends and opportunities; pinpointing regulatory submission requirements for the U.S., Europe, and emerging markets and determining the best documentation approach for speed to market; applying the latest technology in sequencing, molecular diagnostics, wireless, and point of care devices to enhance your IVD product portfolio; and tackling challenges in regulatory approval, pricing, co-development, and relationship management when developing a companion diagnostic.

The conference is suited for IVD manufacturers looking for key regulatory, business and technical updates, as well as pharmaceutical companies looking to enter the personalized medicine arena. All top-level professionals from the following functions will benefit: companion diagnostics, personalized medicine, research and development, business development, manufacturing, regulatory affairs, innovation, pipeline/portfolio, and planning and project management.

The partnership with IVD Business Strategy Conference is part of Frost & Sullivan's Life Sciences Growth Partnership Service program.  Connect with us on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About MD+DI
Medical Device + Diagnostic Industry (MD+DI) is a magazine and information resource exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. For more than 30 years, MD+DI has been the leading industry source of in-depth news and information to help industry professionals develop, design and manufacture medical products that comply with complex and demanding regulations and market requirements. Please visit www.mddionline.com for more information.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.247.2450
F: 210.348.1003
E: jennifer.carson@frost.com
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Turkey Businessman, Two Years Without a Human Heart, Goes Four-Wheeling
2. Anti-Adhesion Products - Global Strategic Business Report
3. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
4. Dental Restorative Supplies - Global Strategic Business Report - 2013-2018
5. University of Miami Program To Train Health Care Executives on Tackling Ethical and Compliance Issues When Doing Business in Latin America
6. Medbox CEO Featured on FOX Business Network
7. GlySure Wins 2013 Small Business of the Year and New Product of the Year
8. Dental Prosthetic Supplies - Global Strategic Business Report 2013-2018 - Aging Global Population is a Major Growth Propeller
9. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
10. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
11. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):